EVGN
Evogene Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.37
−4.71%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 14.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.77x
- Price / sales
- 4.45x
- Price / cash flow
- -0.50x
Enterprise value
- Enterprise value
- $7.6M
- EV / sales
- 5.83x
- EV / EBITDA
- -0.61x
- EV / EBIT
- -0.56x
- Market cap
- $5.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026